Related Articles
Safety and efficacy of anaplastic lymphoma kinase tyrosine kinase inhibitors in non‑small cell lung cancer (Review)
Benefit from a high dose of gefitinib in a woman with lung adenocarcinoma and an epidermal growth factor receptor tyrosine-kinase acquired mutation
Atypical skin reaction in a patient treated with gefitinib for advanced lung cancer: A case report and review of the literature
Tyrosine kinase inhibitors in breast cancer (Review)
Pazopanib-induced asymptomatic radiological acute pancreatitis: A case report